Valuation: Ind-Swift Laboratories Limited

Market Cap 3.53TCr 37Cr 32Cr 30Cr 28Cr 52Cr 52Cr 363.66Cr 140.33Cr 1.8TCr 138.54Cr 135.51Cr 5.81TCr P/E 2025
2.38x
P/E 2026 26.1x
Enterprise Value 3.11TCr 32Cr 28Cr 27Cr 24Cr 46Cr 46Cr 320.22Cr 123.57Cr 1.59TCr 121.99Cr 119.32Cr 5.11TCr EV / Sales 2025
0.12x
EV / Sales 2026 1.11x
Free-Float
36.27%
Yield 2025 *
-
Yield 2026 -
1 day-0.12%
1 week+11.31%
Current month+11.01%
1 month+23.77%
3 months+109.50%
6 months+202.21%
Current year+359.50%
1 week 362.45
Extreme 362.45
417
1 month 316.61
Extreme 316.61
417
Current year 87.25
Extreme 87.25
417
1 year 87.15
Extreme 87.15
417
3 years 68.72
Extreme 68.72
417
5 years 52.65
Extreme 52.65
417
10 years 15
Extreme 15
417
Manager TitleAgeSince
Chief Executive Officer 74 04/01/1995
Chief Executive Officer 44 15/06/2011
Director of Finance/CFO - 29/09/2018
Director TitleAgeSince
Director/Board Member 44 -
Chairman 74 -
Director/Board Member 35 23/03/2010
Date Insider Type Main position Quantity % Market Cap. Importance
12/09/24 Sell

Chief Financial Officer

30,000 0.0508%
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%+11.31%+289.85%+371.81% 37Cr
+1.01%+0.62%+14.33%+65.92% 4.63TCr
-1.02%-2.67%+38.33%+108.43% 3.71TCr
+0.67%+5.65%+11.99%+93.93% 1.21TCr
-0.08%+1.84%-9.44%+17.27% 1.17TCr
-0.19%-0.19%+19.59%+140.28% 899.06Cr
+0.24%+0.24%+25.92%+39.17% 725.37Cr
+0.55%+2.70%+22.72%+215.07% 726.6Cr
-0.06%+1.51%+38.94%-16.76% 713.29Cr
-0.67%+5.34%-39.90%+11.48% 515.75Cr
Average +0.03%+2.38%+41.23%+104.66% 1.43TCr
Weighted average by Cap. +0.11%+0.83%+19.73%+80.90%

Financials

2025 2026
Net sales 561.71Cr 5.88Cr 5.13Cr 4.83Cr 4.4Cr 8.27Cr 8.27Cr 58Cr 22Cr 286.85Cr 22Cr 22Cr 924.76Cr 649.14Cr 6.79Cr 5.93Cr 5.58Cr 5.09Cr 9.55Cr 9.55Cr 67Cr 26Cr 331.5Cr 26Cr 25Cr 1.07TCr
Net income 250.48Cr 2.62Cr 2.29Cr 2.15Cr 1.96Cr 3.69Cr 3.69Cr 26Cr 9.97Cr 127.91Cr 9.84Cr 9.62Cr 412.37Cr 43Cr 45.11L 39.42L 37.05L 33.81L 63.46L 63.47L 4.45Cr 1.72Cr 22Cr 1.69Cr 1.66Cr 71Cr
Net Debt -426.55Cr -4.46Cr -3.9Cr -3.66Cr -3.34Cr -6.28Cr -6.28Cr -44Cr -17Cr -217.83Cr -17Cr -16Cr -702.24Cr -421.25Cr -4.41Cr -3.85Cr -3.62Cr -3.3Cr -6.2Cr -6.2Cr -43Cr -17Cr -215.12Cr -17Cr -16Cr -693.51Cr
Logo Ind-Swift Laboratories Limited
Ind-Swift Laboratories Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (APIs), intermediates and formulations. The Company operates in the Pharmaceutical Business segment. It also focuses on manufacturing formulations. The Company’s products include APIs and Impurities. Its APIs therapeutic category includes Macrolide Antibiotic, Cardiovascular, Antihistaminic, Antidiabetic, Antipsyhotic, Bone Resorption Inhibitor, and Aromatase Inhibitor. Its products include Clarithromycin, Clarithromycin Coated Granules, Clarithromycin Citrate, Atorvastatin Calcium Crystalline, Atorvastatin Calcium Amorphous, Clopidogrel HCl, Ezetimibe, Ivabradine Oxalate, Ranolazine, Aripiprazole, Risedronate Sodium, Ropinirole HCl, Cinacalcet HCl, Letrozole, and Anastrozole. Its products under development include Sitagliptin Phosphate, Mirabegron, Bempedoic Acid, Lasmiditan, and Eltrombopag Olamine.
Employees
1,388
Date Price Change Volume
23/26/23 405.05 -0.12% 8,07,681
22/26/22 ₹405.55 +6.89% 20,18,474
21/26/21 ₹379.40 +1.65% 7,62,788
18/26/18 ₹373.25 -1.32% 3,99,757
17/26/17 ₹378.25 +3.94% 5,45,009
  1. Stock Market
  2. Stocks
  3. INDSWFTLAB Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!